During programmed cell death, activation of caspase-3 leads to proteolysis
of DNA repair proteins, cytoskeletal proteins, and the inhibitor of caspase
-activated deoxyribonuclease, culminating in morphologic changes and DNA da
mage defining apoptosis, The participation of caspase-3 activation in the e
volution of neuronal death after traumatic brain injury in rats was examine
d. Cleavage of pro-caspase-3 in cytosolic cellular fractions and an increas
e in caspase-3-like enzyme activity were seen in injured brain versus contr
ol. Cleavage of the caspase-3 substrates DNA-dependent protein kinase and i
nhibitor of caspase-activated deoxyribonuclease and co-localization of cyto
solic caspase-3 in neurons with evidence of DNA fragmentation were also ide
ntified. Intracerebral administration of the caspase-3 inhibitor N-benzylox
ycarbonyl-Asp-Glu-Val-Asp-fluomethyl ketone (480 ng) after trauma reduced c
aspase-3-like activity and DNA fragmentation in injured brain versus vehicl
e at 24 h. Treatment with N-benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethyl
ketone for 72 h (480 ng/day) reduced contusion size and ipsilateral dorsal
hippocampal tissue loss at 3 weeks but had no effect on functional outcome
versus vehicle. These data demonstrate that caspase-3 activation contribute
s to brain tissue loss and downstream biochemical events that execute progr
ammed cell death after traumatic brain injury. Caspase inhibition may prove
efficacious in the treatment of certain types of brain injury where progra
mmed cell death occurs.